Stockscreener 앱 받기
2.83
19.92%
0.47
전일 마감가:
$2.36
열려 있는:
$2.92
하루 거래량:
39,166
Relative Volume:
0.06
시가총액:
$5.93M
수익:
$7.11M
순이익/손실:
$-41.28M
주가수익비율:
-2.0507
EPS:
-1.38
순현금흐름:
$-26.84M
1주 성능:
-54.28%
1개월 성능:
-61.67%
6개월 성능:
-64.02%
1년 성능:
-87.83%
1일 변동 폭
$2.70
$2.92
1주일 범위
$2.36
$6.18
52주 변동 폭
$2.36
$46.50
Co Diagnostics Inc Stock (CODX) Company Profile
명칭
Co Diagnostics Inc
전화
(801) 278-9769
주소
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
CODX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
2.83 | 4.94M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-12 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2021-12-29 | 개시 | Sidoti | Buy |
| 2021-03-29 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-05-20 | 업그레이드 | Maxim Group | Hold → Buy |
| 2020-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
Co Diagnostics Inc 주식(CODX)의 최신 뉴스
Co-Diagnostics Shares Transition to Over-the-Counter Trading - AD HOC NEWS
Co-Diagnostics Faces Nasdaq Delisting After Bid Price Noncompliance - The Globe and Mail
Co-Diagnostics (CODX) Price Target Increased by 2,900.00% to 38.25 - Nasdaq
Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market By Investing.com - Investing.com India
Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market - Investing.com Nigeria
Co-Diagnostics Received Notice of Delisting - TradingView — Track All Markets
Co-Diagnostics, Inc.(OTCPK: CODX) dropped from NASDAQ Composite Index - marketscreener.com
Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships - Barchart.com
Why Co Diagnostics Inc. stock could be next big winnerShare Buyback & Stepwise Trade Execution Plans - Улправда
CODX stock plunges to all-time lows on 1-for-30 reverse stock split approval - MSN
Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention and Expo on Oct 2-3 - marketscreener.com
CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform - Finviz
Co-Diagnostics Approves Reverse Stock Split to Maintain Listing - The Globe and Mail
Co-Diagnostics announces 1-for-30 reverse stock split - Yahoo Finance
Institution Moves: Is Co Diagnostics Inc stock a buy in volatile marketsDip Buying & Daily Volume Surge Trade Alerts - moha.gov.vn
Co-Diagnostics (CODX) Announces 1-for-30 Reverse Stock Split - GuruFocus
Co-Diagnostics to Effect a 1-for-30 Reverse Stock Split - MarketScreener
CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval - Stocktwits
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split By Investing.com - Investing.com South Africa
Co-Diagnostics announces 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split - Investing.com Canada
Co-Diagnostics Announces Reverse Stock Split - Financial Times
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies - The Malaysian Reserve
Co-Diagnostics Receives Grant of Australian Patent Covering Co-D - GuruFocus
Co-Diagnostics (CODX) Secures Australian Patent for PCR Platform - GuruFocus
Co-diagnostics receives Australian patent for PCR testing platform By Investing.com - Investing.com India
Co-diagnostics receives Australian patent for PCR testing platform - Investing.com
Co-Diagnostics Q3 2025 Earnings Preview - MSN
Can Co-Diagnostics Stock Recover If Markets Fall? - Trefis
Aug Breakouts: How resilient is Co Diagnostics Inc. stock in market downturns - Улправда
Can Co Diagnostics Inc. stock sustain market leadershipWeekly Trade Report & Low Drawdown Momentum Trade Ideas - Улправда
Why Co Diagnostics Inc. stock is seen as undervaluedJuly 2025 Update & Stepwise Trade Signal Guides - Улправда
Will Co Diagnostics Inc. stock deliver consistent dividends2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - DonanımHaber
Can Co Diagnostics Inc. stock weather global recession2025 Trading Volume Trends & Reliable Price Breakout Signals - ulpravda.ru
Bond Watch: Is Co Diagnostics Inc. stock a buy in volatile markets2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - DonanımHaber
How resilient is Co Diagnostics Inc. stock in market downturnsPortfolio Risk Summary & AI Forecast Swing Trade Picks - Улправда
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in - GuruFocus
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India - Barchart.com
Inside a global effort to improve TB testing across South Asia this week - Stock Titan
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Con - GuruFocus
Co-Diagnostics (CODX) Validates Efficacy of Influenza and COVID-19 Detection Test - GuruFocus
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation - Nasdaq
Co Diagnostics Inc Stock Analysis and ForecastRisk Mitigation Techniques & Affordable Trading Techniques - earlytimes.in
Certain Warrants of Co-Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
Co Diagnostics Inc (CODX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):